According to Streamline Health Solutions's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.455. At the end of 2022 the company had a P/E ratio of -7.87.
Year | P/E ratio | Change |
---|---|---|
2022 | -7.87 | 6.47% |
2021 | -7.40 | -66.81% |
2020 | -22.3 | -164.13% |
2019 | 34.8 | -692.49% |
2018 | -5.87 | -27.18% |
2017 | -8.05 | 125.52% |
2016 | -3.57 | 24.11% |
2015 | -2.88 | -61.46% |
2014 | -7.47 | 54.02% |
2013 | -4.85 | -116.29% |
2012 | 29.7 | -428.61% |
2011 | -9.05 | -122.08% |
2010 | 41.0 | -187.98% |
2009 | -46.6 | 41.21% |
2008 | -33.0 | 153.85% |
2007 | -13.0 | -159.49% |
2006 | 21.9 | -43% |
2005 | 38.3 | -113.74% |
2004 | -279 | -530.56% |
2003 | 64.8 | 82.54% |
2002 | 35.5 | -66.82% |
2001 | 107 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.